Log In Sign up
The largest database of trusted experimental protocols

Alexa fluor 488 conjugated anti cd20 clone h1 fb1

Manufactured by BD
Visit Supplier
Sourced in United States

Alexa Fluor® 488 conjugated anti‐CD20 (clone H1 (FB1)) is a fluorescently labeled antibody that binds to the CD20 cell surface antigen. This product is designed for use in flow cytometry and other immunoassay applications.

Automatically generated - may contain errors

Lab products found in correlation

Anti stat5, by BD (2 mentions) Alexa fluor 647 conjugated anti stat4, by BD (2 mentions) Pe conjugated anti cd56 clone n901, by Beckman Coulter (2 mentions) Anti stat1, by BD (2 mentions) Anti p38 mapk, by BD (1 mentions) Anti nf κb p65, by BD (1 mentions)

Spelling variants of this product

Alexa Fluor 488 (45 citations) Alexa 488 (11 citations) Anti-CD20 (10 citations)

2 protocols using alexa fluor 488 conjugated anti cd20 clone h1 fb1

1

Phospho-specific Antibodies for Multiparameter Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following phospho‐specific monoclonal antibodies were used in 3 different panels during the flow cytometry protocol as described previously 34: Alexa Fluor® 647 conjugated anti‐STAT4 (pY693, clone 38/p‐STAT4, panel 1), anti‐STAT1 (pS727, clone K51‐856, panel 2) and anti‐STAT3 (pS727, clone 49/p‐STAT3, panel 3); PerCP‐Cy™5.5 conjugated anti‐ERK1/2 (pT202/pY204, clone 20A, panel 1), anti‐STAT1 (pY701, clone 4a, panel 2) and anti‐STAT3 (pY705, clone 4/P‐STAT3, panel 3); and PE‐Cy™7 conjugated anti‐NF‐κB p65 (pS529, clone K10‐895.12.50, panel 1), anti‐p38 MAPK (pT180/pY182, clone 36/p38, panel 2) and anti‐STAT5 (pY694, clone 47/ STAT5(pY694), panel 3) (all from BD Biosciences, San Jose, CA, USA). Cell surface markers incorporated in the assays were BV786 conjugated anti‐CD3 (clone SK7, BD HorizonTM), Alexa Fluor® 488 conjugated anti‐CD20 (clone H1 (FB1), BD Biosciences) and PE conjugated anti‐CD56 (clone N901, Beckmann Coulter, CA, USA).
Davies R., Hammenfors D., Bergum B., Vogelsang P., Gavasso S., Brun J.G., Jonsson R, & Appel S. (2018). Aberrant cell signalling in PBMCs upon IFN‐α stimulation in primary Sjögren's syndrome patients associates with type I interferon signature. European Journal of Immunology, 48(7), 1217-1227.
+ Open protocol
+ Expand
2

Comprehensive Phospho-Protein Profiling by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following phospho-specific monoclonal antibodies were used in 3 different panels during the flow cytometry protocol described previously (17 (link)): Alexa Fluor®647 conjugated anti-STAT4 (pY693, clone 38/p-STAT4, panel 1), anti-STAT 1 (pS727, clone K51-856, panel 2), and anti-STAT3 (pS727, clone 49/p-STAT3, panel 3); PerCP-CyTM 5.5 conjugated anti-ERK1/2 (pT202/pY204, clone 20A, panel 1), anti-STAT1 (pY701, clone 4a, panel 2), and anti-STAT3 (pY705, clone 4/P-STAT3, panel 3); and PE-CyTM7 conjugated anti-p38 MAPK (pT180/pY182, clone 36/p38, panel 2), and anti NF-κB p65 (pS529, clone K10-895.12.50, panel 1), anti-STAT5 (pY694, clone 47/STAT5(pY694), panel 3) (all from BD Biosciences, San Jose, CA, USA). Cell surface markers incorporated in the assays were BV786 conjugated anti-CD3 (clone SK7, BD HorizonTM), Alexa Fluor® 488 conjugated anti-CD20 (clone H1 (FB1), BD Biosciences) and PE conjugated anti-CD56 (clone N901, Beckmann Coulter, CA, USA).
Davies R., Sarkar I., Hammenfors D., Bergum B., Vogelsang P., Solberg S.M., Gavasso S., Brun J.G., Jonsson R, & Appel S. (2019). Single Cell Based Phosphorylation Profiling Identifies Alterations in Toll-Like Receptor 7 and 9 Signaling in Patients With Primary Sjögren's Syndrome. Frontiers in Immunology, 10, 281.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!